The presence of strong family histories of leukemia in individuals with deleterious germline CHEK2 variants who were tested for inherited cancer risk based on solid tumor history suggests that it is the P/LP CHEK2 variant driving the observed HM predisposition, rather than being a second order effect arising from the selected nature of our HHM cohort. This evidence concerns the gene CHEK2 and cancer.